EyePoint Pharmaceuticals, Inc. (EYPT)
USD 4.66
(-6.71%)
USD 4.66
(-6.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -275.79 Million USD | -453.09% |
| 2022 | -49.86 Million USD | 64.43% |
| 2021 | -140.17 Million USD | -2945.87% |
| 2020 | -4.6 Million USD | -116.21% |
| 2019 | 28.38 Million USD | 232.24% |
| 2018 | -21.46 Million USD | -5323.11% |
| 2017 | 411 Thousand USD | 102.68% |
| 2016 | -15.31 Million USD | 19.92% |
| 2015 | -19.12 Million USD | -24.7% |
| 2014 | -15.33 Million USD | -122.26% |
| 2013 | -6.89 Million USD | -49.17% |
| 2012 | -4.62 Million USD | 64.18% |
| 2011 | -12.91 Million USD | 16.77% |
| 2010 | -15.51 Million USD | -124.87% |
| 2009 | -6.89 Million USD | 55.8% |
| 2008 | -15.6 Million USD | -485.04% |
| 2007 | -2.66 Million USD | -1153.04% |
| 2006 | -212.92 Thousand USD | 97.83% |
| 2005 | -9.79 Million USD | 55.06% |
| 2004 | -21.78 Million USD | -2647.88% |
| 2003 | -792.81 Thousand USD | 0.0% |
| 2001 | -1.49 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -265.29 Million USD | 3.81% |
| 2024 Q2 | -67.47 Million USD | 74.57% |
| 2023 Q2 | -134.14 Million USD | -105.18% |
| 2023 Q3 | -127.85 Million USD | 4.69% |
| 2023 FY | -275.79 Million USD | -453.09% |
| 2023 Q1 | -65.37 Million USD | -31.11% |
| 2023 Q4 | -275.79 Million USD | -115.72% |
| 2022 Q3 | -29.4 Million USD | 21.91% |
| 2022 FY | -49.86 Million USD | 64.43% |
| 2022 Q1 | -60.26 Million USD | 57.01% |
| 2022 Q2 | -37.65 Million USD | 37.52% |
| 2022 Q4 | -49.86 Million USD | -69.6% |
| 2021 Q3 | -81.29 Million USD | 9.05% |
| 2021 Q2 | -89.38 Million USD | 9.06% |
| 2021 Q1 | -98.28 Million USD | -2035.66% |
| 2021 Q4 | -140.17 Million USD | -72.42% |
| 2021 FY | -140.17 Million USD | -2945.87% |
| 2020 Q1 | 24.18 Million USD | -14.82% |
| 2020 Q2 | 30.07 Million USD | 24.36% |
| 2020 Q3 | 24.53 Million USD | -18.42% |
| 2020 Q4 | -4.6 Million USD | -118.76% |
| 2020 FY | -4.6 Million USD | -116.21% |
| 2019 Q2 | 5.67 Million USD | 173.33% |
| 2019 Q1 | -7.74 Million USD | 71.98% |
| 2019 Q4 | 28.38 Million USD | 53.76% |
| 2019 Q3 | 18.46 Million USD | 225.09% |
| 2019 FY | 28.38 Million USD | 232.24% |
| 2018 Q3 | -38.3 Million USD | -78.42% |
| 2018 FY | -21.46 Million USD | -5323.11% |
| 2018 Q1 | -3.49 Million USD | 72.85% |
| 2018 Q2 | -21.46 Million USD | -514.04% |
| 2018 Q4 | -27.64 Million USD | 27.83% |
| 2017 FY | 411 Thousand USD | 102.68% |
| 2017 Q4 | -12.87 Million USD | -8.81% |
| 2017 Q3 | -11.83 Million USD | 29.97% |
| 2017 Q2 | -16.89 Million USD | -31.29% |
| 2017 Q1 | -12.87 Million USD | -10.15% |
| 2016 Q3 | -14.3 Million USD | 6.56% |
| 2016 Q2 | -15.31 Million USD | 38.42% |
| 2016 FY | -15.31 Million USD | 19.92% |
| 2016 Q1 | -24.86 Million USD | -121.83% |
| 2016 Q4 | -11.68 Million USD | 18.33% |
| 2015 FY | -19.12 Million USD | -24.7% |
| 2015 Q2 | -19.12 Million USD | 16.89% |
| 2015 Q4 | -11.21 Million USD | 20.43% |
| 2015 Q3 | -14.08 Million USD | 26.32% |
| 2015 Q1 | -23 Million USD | 22.67% |
| 2014 FY | -15.33 Million USD | -122.26% |
| 2014 Q4 | -29.75 Million USD | -161.34% |
| 2014 Q1 | -18.55 Million USD | -21.92% |
| 2014 Q3 | -11.38 Million USD | 25.76% |
| 2014 Q2 | -15.33 Million USD | 17.36% |
| 2013 Q2 | -6.89 Million USD | 13.74% |
| 2013 FY | -6.89 Million USD | -49.17% |
| 2013 Q4 | -15.21 Million USD | -4.63% |
| 2013 Q3 | -14.54 Million USD | -110.84% |
| 2013 Q1 | -7.99 Million USD | 15.0% |
| 2012 Q1 | -6.37 Million USD | 24.18% |
| 2012 FY | -4.62 Million USD | 64.18% |
| 2012 Q4 | -9.4 Million USD | 46.68% |
| 2012 Q3 | -17.64 Million USD | -281.54% |
| 2012 Q2 | -4.62 Million USD | 27.45% |
| 2011 Q2 | -12.91 Million USD | 2.89% |
| 2011 Q1 | -13.29 Million USD | 0.0% |
| 2011 FY | -12.91 Million USD | 16.77% |
| 2011 Q3 | -9.81 Million USD | 24.02% |
| 2011 Q4 | -8.4 Million USD | 14.3% |
| 2010 Q1 | -3.97 Million USD | 22.58% |
| 2010 FY | -15.51 Million USD | -124.87% |
| 2010 Q4 | - USD | 100.0% |
| 2010 Q3 | -10.12 Million USD | 34.73% |
| 2010 Q2 | -15.51 Million USD | -290.68% |
| 2009 Q4 | -5.12 Million USD | 13.99% |
| 2009 Q3 | -5.96 Million USD | 13.57% |
| 2009 Q2 | -6.89 Million USD | 13.97% |
| 2009 Q1 | -8.01 Million USD | 18.58% |
| 2009 FY | -6.89 Million USD | 55.8% |
| 2008 Q2 | -15.6 Million USD | 14.12% |
| 2008 Q1 | -18.17 Million USD | -85.78% |
| 2008 Q4 | -9.84 Million USD | 10.32% |
| 2008 FY | -15.6 Million USD | -485.04% |
| 2008 Q3 | -10.98 Million USD | 29.64% |
| 2007 FY | -2.66 Million USD | -1153.04% |
| 2007 Q4 | -9.78 Million USD | 40.54% |
| 2007 Q2 | -2.66 Million USD | 0.0% |
| 2007 Q3 | -16.45 Million USD | -516.72% |
| 2006 Q2 | -212.92 Thousand USD | 0.0% |
| 2006 Q4 | 4.81 Million USD | 0.0% |
| 2006 FY | -212.92 Thousand USD | 97.83% |
| 2005 Q2 | -9.79 Million USD | 0.0% |
| 2005 FY | -9.79 Million USD | 55.06% |
| 2004 Q2 | -21.78 Million USD | 0.0% |
| 2004 FY | -21.78 Million USD | -2647.88% |
| 2003 FY | -792.81 Thousand USD | 0.0% |
| 2003 Q2 | -792.81 Thousand USD | 0.0% |
| 2001 FY | -1.49 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -393.018% |
| Alkermes plc | -166.73 Million USD | -65.405% |
| Agenus Inc. | 274.13 Million USD | 200.605% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 114.749% |
| Aptorum Group Limited | 1.35 Million USD | 20423.114% |
| Ardelyx, Inc. | 34.51 Million USD | 899.125% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6543.785% |
| Bicycle Therapeutics plc | -481.46 Million USD | 42.718% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 862.641% |
| ChromaDex Corporation | -24.04 Million USD | -1046.848% |
| Chimerix, Inc. | -25.51 Million USD | -980.825% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4057.965% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1064.818% |
| CRISPR Therapeutics AG | -150.84 Million USD | -82.833% |
| Precision BioSciences, Inc. | -85.41 Million USD | -222.906% |
| Dyadic International, Inc. | -6.37 Million USD | -4224.078% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1630.961% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3698.095% |
| Lantern Pharma Inc. | -21.7 Million USD | -1170.748% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -149.504% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3128.237% |
| Incyte Corporation | -3.17 Billion USD | 91.314% |
| IO Biotech, Inc. | -140.69 Million USD | -96.017% |
| Jaguar Health, Inc. | 29.39 Million USD | 1038.362% |
| Novavax, Inc. | -298.29 Million USD | 7.543% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5267.585% |
| Opthea Limited | 28.15 Million USD | 1079.471% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1542.707% |
| ContextLogic Inc. | -232 Million USD | -18.877% |
| MiMedx Group, Inc. | -33.9 Million USD | -713.528% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2805.189% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -11802.926% |
| NextCure, Inc. | -6.47 Million USD | -4158.052% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -446.116% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4223.468% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2367.434% |
| Vaxcyte, Inc. | -368.22 Million USD | 25.102% |
| PDS Biotechnology Corporation | -32.7 Million USD | -743.177% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1696.215% |
| Pharming Group N.V. | 109.8 Million USD | 351.169% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1485.387% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -57.39% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1389.18% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1389.18% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3784.423% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4606.382% |
| Acelyrin, Inc. | -216.9 Million USD | -27.151% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4815.88% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -15897.332% |
| Summit Therapeutics Inc. | 34.67 Million USD | 895.391% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3954.006% |
| Senti Biosciences, Inc. | 1.74 Million USD | 15950.23% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -49.395% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -256.088% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4449.555% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 276532.559% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 44016.242% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -135.629% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -63.936% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 348.754% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3530.779% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -113.605% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4100.146% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -13.794% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1475.084% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 12.917% |
| MEI Pharma, Inc. | -3.7 Million USD | -7343.833% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2304.412% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 270.515% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1092.315% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3698.095% |
| Precigen, Inc. | -481 Thousand USD | -57237.63% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2058.625% |
| AlloVir, Inc. | -62.69 Million USD | -339.919% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -395.908% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 547.238% |
| ImmuCell Corporation | 10.99 Million USD | 2609.371% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -78.917% |
| Onconetix, Inc. | 5.33 Million USD | 5272.977% |
| PureTech Health plc | -167.19 Million USD | -64.952% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -805.43% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1342.588% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5518.13% |
| Seer, Inc. | -4.24 Million USD | -6404.575% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1047.373% |
| Innoviva, Inc. | 255.56 Million USD | 207.916% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -393.688% |
| ESSA Pharma Inc. | -33.62 Million USD | -720.289% |
| GlycoMimetics, Inc. | -40.98 Million USD | -572.924% |
| GT Biopharma, Inc. | -1.02 Million USD | -26912.145% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -306.878% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 550.224% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -105.695% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1890.43% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -855.23% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -365994.99% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -793.636% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3265.452% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -8714.075% |
| Soligenix, Inc. | -4.95 Million USD | -5469.799% |
| Century Therapeutics, Inc. | 847 Thousand USD | 32661.275% |
| Kura Oncology, Inc. | -20.11 Million USD | -1270.882% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -573.885% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3184.044% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 15239.417% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -8526.65% |
| Autolus Therapeutics plc | -186.59 Million USD | -47.8% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -459.374% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 904.815% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 267.791% |
| GRI Bio, Inc. | -1.79 Million USD | -15273.133% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2970.161% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -729.281% |
| IGM Biosciences, Inc. | -72.6 Million USD | -279.85% |
| INmune Bio, Inc. | -25.41 Million USD | -985.333% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 282.704% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -444.413% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1597.259% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -9459.829% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 825.487% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -569.647% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 964.965% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 172.971% |
| Verastem, Inc. | -37.27 Million USD | -639.83% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2939.722% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -431.784% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1722.227% |
| Histogen Inc. | -7.48 Million USD | -3583.638% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1176.421% |
| Surrozen, Inc. | -32.66 Million USD | -744.336% |
| Organovo Holdings, Inc. | -1.5 Million USD | -18200.863% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6461.075% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1554.594% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 10642.584% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 6736.044% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3190.646% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -534.856% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1791.999% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 12.941% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -38095.441% |
| Apollomics, Inc. | -27.39 Million USD | -906.731% |
| Amarin Corporation plc | -191.04 Million USD | -44.365% |
| Mesoblast Limited | 55.96 Million USD | 592.815% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1791.072% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -990.44% |
| Synaptogenix, Inc. | -28.66 Million USD | -862.246% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -29365.171% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 665.94% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -31891.361% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3695.637% |
| Exelixis, Inc. | -73.05 Million USD | -277.541% |
| Better Therapeutics, Inc. | -860 Thousand USD | -31969.07% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1048.52% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -14.261% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 37568.651% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3607.838% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 22093.142% |
| Gritstone bio, Inc. | 39.49 Million USD | 798.389% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -227.932% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -10377.938% |
| Avid Bioservices, Inc. | 169.72 Million USD | 262.492% |
| Insmed Incorporated | 721.62 Million USD | 138.219% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2916.941% |
| MediWound Ltd. | -5.32 Million USD | -5082.15% |
| OmniAb, Inc. | 9.2 Million USD | 3096.784% |
| Alector, Inc. | -35.63 Million USD | -673.898% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 420.799% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5496.469% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2183.194% |
| Zai Lab Limited | -775 Million USD | 64.414% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 180.984% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1181.273% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -234.377% |
| Immunic, Inc. | -45.34 Million USD | -508.28% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -42.739% |
| Veracyte, Inc. | -203.82 Million USD | -35.31% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 143.208% |
| FibroGen, Inc. | 56.76 Million USD | 585.835% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3197.069% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -9655.43% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -13221.142% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.008% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -8154.834% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -66.177% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1644.026% |
| Galecto, Inc. | -21.21 Million USD | -1199.934% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1059.529% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 117.573% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1026.978% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2296.75% |
| XBiotech Inc. | -200.02 Million USD | -37.881% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -227.932% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6190.857% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -682.106% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -257.163% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4946.143% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -61.837% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -198.562% |
| Vaxxinity, Inc. | 10.13 Million USD | 2822.009% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 137.458% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2461.344% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -318.148% |
| NexImmune, Inc. | -3.13 Million USD | -8701.066% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -7887.84% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1725.066% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -917.69% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2972.553% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -221287.919% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -579.764% |
| Ainos, Inc. | 4.07 Million USD | 6863.091% |
| Pluri Inc. | 22.82 Million USD | 1308.086% |
| Prothena Corporation plc | -608.34 Million USD | 54.665% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -132.236% |
| Celularity Inc. | 65.19 Million USD | 523.062% |
| Rallybio Corporation | -24.1 Million USD | -1044.278% |
| Cue Biopharma, Inc. | -33.81 Million USD | -715.5% |
| MeiraGTx Holdings plc | -40.3 Million USD | -584.318% |
| Omeros Corporation | 331.17 Million USD | 183.277% |
| Humacyte, Inc. | -22.48 Million USD | -1126.514% |
| Immunocore Holdings plc | -358.59 Million USD | 23.09% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1022.254% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -792.508% |
| Blueprint Medicines Corporation | 702.83 Million USD | 139.24% |
| CalciMedica, Inc. | -5.53 Million USD | -4887.233% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -46.527% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2600.157% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -588.848% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -729.381% |
| Pulmatrix, Inc. | -10.41 Million USD | -2547.538% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4514.255% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -623.072% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -147.566% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -360.086% |
| Cytokinetics, Incorporated | 642.37 Million USD | 142.934% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4636.287% |
| Nutriband Inc. | -251.65 Thousand USD | -109491.229% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -708.33% |
| Vor Biopharma Inc. | 4.3 Million USD | 6513.814% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.431% |
| Evogene Ltd. | -19.63 Million USD | -1304.676% |
| ProKidney Corp. | -56.23 Million USD | -390.423% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -466.638% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2885.693% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 120.221% |
| CorMedix Inc. | -43.05 Million USD | -540.599% |
| BioLineRx Ltd. | 7.33 Million USD | 3859.46% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -904.165% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 697.642% |
| Atai Life Sciences N.V. | -28.55 Million USD | -865.733% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 12464.511% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1108.775% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1655.083% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -267.363% |
| MediciNova, Inc. | -50.78 Million USD | -443.078% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -249.97% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1225923.561% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4174.16% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -38.021% |
| Biomea Fusion, Inc. | -166.57 Million USD | -65.572% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -54.096% |
| Mereo BioPharma Group plc | -51.46 Million USD | -435.845% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -190.787% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 6.116% |
| Absci Corporation | -72.59 Million USD | -279.892% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6140.166% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -17.641% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -192.741% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -188.198% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -605.843% |
| Allakos Inc. | -24.97 Million USD | -1004.28% |
| Imunon, Inc. | -4.21 Million USD | -6444.938% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1770.805% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -103.688% |
| BioAtla, Inc. | -109.01 Million USD | -152.996% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 37568.651% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -29271.033% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2404.814% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1200.731% |
| XOMA Corporation | -29 Million USD | -851.014% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1565.423% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2958.94% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3602.43% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -121.28% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -32.489% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -237.243% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -197.31% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -31999.527% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7072.796% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 17094.005% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 119.972% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -23112.345% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6380.893% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 343.031% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 383349.493% |
| Orgenesis Inc. | 21.78 Million USD | 1366.039% |
| Entera Bio Ltd. | -10.62 Million USD | -2494.731% |
| GH Research PLC | -78.07 Million USD | -253.233% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1137.41% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -934.525% |
| Xencor, Inc. | 29.64 Million USD | 1030.354% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -13901.032% |
| Replimune Group, Inc. | 1.41 Million USD | 19632.153% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -112511.266% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -118.162% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -23112.345% |
| Portage Biotech Inc. | -4.98 Million USD | -5436.92% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1225923.561% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -317.099% |
| OncoCyte Corporation | -6.56 Million USD | -4102.255% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 30832.116% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5953.898% |
| Purple Biotech Ltd. | -14.13 Million USD | -1850.729% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1060.945% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4113.812% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1552.236% |
| HilleVax, Inc. | -165.48 Million USD | -66.658% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -10766.588% |
| Tharimmune, Inc. | -10.93 Million USD | -2422.04% |
| Genprex, Inc. | -6.73 Million USD | -3993.339% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 25.22% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -211.773% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -19585.51% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -8214.697% |
| OKYO Pharma Limited | -826.84 Thousand USD | -33254.861% |
| Savara Inc. | 153 Thousand USD | 180357.516% |
| Curis, Inc. | -23.88 Million USD | -1054.578% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5247.01% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -35439.914% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4342.558% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 23373.755% |
| BeiGene, Ltd. | -2.25 Billion USD | 87.759% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2335.231% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 54.654% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -48.607% |
| Erasca, Inc. | -37.21 Million USD | -641.063% |
| bluebird bio, Inc. | 108.57 Million USD | 354.022% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -21314.357% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 172.817% |
| DBV Technologies S.A. | -126.98 Million USD | -117.185% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -21314.357% |
| Moderna, Inc. | -2.9 Billion USD | 90.513% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2564.162% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2437.67% |
| Molecular Templates, Inc. | 707 Thousand USD | 39109.052% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -779.137% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 179.569% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -236.08% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -200.658% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -754.592% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -702.286% |
| MacroGenics, Inc. | -66.98 Million USD | -311.725% |
| RenovoRx, Inc. | -1.17 Million USD | -23411.85% |
| Adicet Bio, Inc. | -138.78 Million USD | -98.717% |
| Prime Medicine, Inc. | -27.94 Million USD | -887.058% |
| Aditxt, Inc. | 18.12 Million USD | 1621.968% |
| Adagene Inc. | -87.62 Million USD | -214.735% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6521.024% |
| Quantum-Si incorporated | -118.55 Million USD | -132.626% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 865.988% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3589.953% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -468.542% |
| SciSparc Ltd. | -2.06 Million USD | -13255.642% |
| Vericel Corporation | 1.27 Million USD | 21697.024% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2199.874% |
| Minerva Neurosciences, Inc. | 41 Million USD | 772.599% |
| Generation Bio Co. | 31.44 Million USD | 976.984% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -57.269% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -791.873% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 336.544% |
| Invivyd, Inc. | -198.47 Million USD | -38.956% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -205.521% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -11402.496% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -289.595% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3940.938% |
| 2seventy bio, Inc. | 181.71 Million USD | 251.773% |
| ADMA Biologics, Inc. | 90.06 Million USD | 406.213% |
| Clene Inc. | 3.34 Million USD | 8357.305% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2936.475% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1182.107% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4174.16% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 19.856% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -960.759% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 255.232% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -6640.547% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5613.675% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5194.567% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -111.654% |
| Evaxion Biotech A/S | 5.28 Million USD | 5316.609% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -145.002% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -110.092% |
| Trevena, Inc. | 2.25 Million USD | 12314.083% |
| Surrozen, Inc. | -32.66 Million USD | -744.336% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -435.418% |
| Cingulate Inc. | 3.08 Million USD | 9046.557% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -9290.33% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3937.401% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2868.327% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -247.685% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -109.806% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -161.312% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6895.166% |
| Kronos Bio, Inc. | -36.05 Million USD | -664.947% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3031.172% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 19014.265% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -408.32% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2013.057% |
| ImmunityBio, Inc. | 618.22 Million USD | 144.611% |
| Korro Bio, Inc. | -132.94 Million USD | -107.453% |
| Kineta, Inc. | -4.54 Million USD | -5973.42% |
| BioVie Inc. | -17.73 Million USD | -1455.315% |
| Codexis, Inc. | -43.27 Million USD | -537.365% |
| Celularity Inc. | 65.19 Million USD | 523.062% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -8602.872% |
| Celcuity Inc. | 6.78 Million USD | 4165.654% |
| Virax Biolabs Group Limited | -3.36 Million USD | -8096.095% |
| Cibus, Inc. | -8.07 Million USD | -3314.137% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6421.494% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 6134.88% |
| IN8bio, Inc. | -16.38 Million USD | -1582.799% |
| Kodiak Sciences Inc. | -103.87 Million USD | -165.506% |
| Annexon, Inc. | -193.75 Million USD | -42.342% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 766194.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1476.056% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -7750.669% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 126.16% |
| Eyenovia, Inc. | 1.25 Million USD | 22010.984% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1125.066% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8404.286% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -729.53% |
| Arcellx, Inc. | -296.95 Million USD | 7.127% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1313.893% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -368.44% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1230.603% |
| Moolec Science SA | 117.61 Thousand USD | 234586.805% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -618.232% |
| Geron Corporation | 14.76 Million USD | 1968.396% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -627.343% |
| Royalty Pharma plc | 5.65 Billion USD | 104.874% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -95.016% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3845.876% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5042.667% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -95.972% |
| Humacyte, Inc. | -22.48 Million USD | -1126.514% |
| Structure Therapeutics Inc. | -124.33 Million USD | -121.808% |
| 89bio, Inc. | -289.05 Million USD | 4.587% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -992.6% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -15367.975% |
| Genelux Corporation | -6.89 Million USD | -3897.594% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -787.968% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 429.901% |
| Notable Labs, Ltd. | -9.77 Million USD | -2721.133% |
| Liquidia Corporation | -80.17 Million USD | -243.986% |
| Mustang Bio, Inc. | -3.73 Million USD | -7282.066% |
| Immunovant, Inc. | -635.22 Million USD | 56.583% |
| Quantum-Si incorporated | -118.55 Million USD | -132.626% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1470.223% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6556.867% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3535.829% |
| Acasti Pharma Inc. | -23 Million USD | -1098.844% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -8090.533% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1597.259% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -100.228% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -8749.87% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1140.527% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1385.239% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -62.924% |
| PepGen Inc. | -60.67 Million USD | -354.581% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1100.357% |
| United Therapeutics Corporation | -507.7 Million USD | 45.678% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1341.985% |
| Solid Biosciences Inc. | -47.75 Million USD | -477.579% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -31891.361% |
| Immuneering Corporation | -54.94 Million USD | -401.965% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6461.075% |
| Silo Pharma, Inc. | -3.52 Million USD | -7725.479% |
| Belite Bio, Inc | -87.27 Million USD | -216.02% |
| XOMA Corporation | -29 Million USD | -851.014% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -290.107% |
| Bionomics Limited | 227 Million USD | 221.49% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -137.177% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10788.038% |
| uniQure N.V. | -102.95 Million USD | -167.889% |
| Cassava Sciences, Inc. | -121.13 Million USD | -127.673% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6521.024% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 773.473% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2205.777% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -8813.257% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 260283.019% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8404.286% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3197.069% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3618.905% |
| Altimmune, Inc. | -134.48 Million USD | -105.071% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 239.244% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10788.038% |
| Compugen Ltd. | -12.9 Million USD | -2037.275% |
| Peak Bio, Inc. | 10.34 Million USD | 2767.213% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -97353.71% |
| Benitec Biopharma Inc. | -50.58 Million USD | -445.241% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -164.327% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1503.889% |
| Zura Bio Limited | -99.8 Million USD | -176.33% |
| PolyPid Ltd. | 6.17 Million USD | 4569.919% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 472.091% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1503.889% |
| Instil Bio, Inc. | 75.35 Million USD | 465.978% |
| argenx SE | -2.02 Billion USD | 86.406% |
| Immunome, Inc. | -97.02 Million USD | -184.239% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1126.024% |
| Verona Pharma plc | -220.44 Million USD | -25.109% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -284.419% |
| Shattuck Labs, Inc. | -121.42 Million USD | -127.133% |
| CervoMed Inc. | -7.79 Million USD | -3439.066% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -48.677% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6206.746% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -109.347% |
| Moolec Science SA | 117.61 Thousand USD | 234586.805% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -11954.055% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1834.73% |
| AnaptysBio, Inc. | -18.15 Million USD | -1419.442% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1419.526% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -291.859% |
| NeurAxis, Inc. | 145.7 Thousand USD | 189388.95% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2555.431% |
| Lumos Pharma, Inc. | -28.49 Million USD | -867.936% |
| Achilles Therapeutics plc | -126.92 Million USD | -117.291% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -284.419% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -41959.079% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1227.603% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 19014.265% |
| Nutriband Inc. | -251.65 Thousand USD | -109491.229% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1993.949% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3606.909% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 181.069% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1261.972% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 38.366% |
| Palisade Bio, Inc. | -12.06 Million USD | -2186.28% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -96.559% |
| Beam Therapeutics Inc. | -262.72 Million USD | -4.976% |
| Neurogene Inc. | -131.95 Million USD | -109.006% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1364.182% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5551.516% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 26.882% |
| Sesen Bio, Inc. | -112.55 Million USD | -145.035% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -176.181% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -11646.947% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -606.693% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -231.157% |
| Athira Pharma, Inc. | -88.99 Million USD | -209.884% |
| Vaccinex, Inc. | -1.28 Million USD | -21312.578% |
| HCW Biologics Inc. | 2.85 Million USD | 9754.368% |
| XOMA Corporation | -29 Million USD | -851.014% |
| Nektar Therapeutics | 210.24 Million USD | 231.181% |
| Arvinas, Inc. | -313.8 Million USD | 12.112% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 17094.005% |
| Merus N.V. | -192.88 Million USD | -42.984% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 559.772% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3875.123% |
| Rezolute, Inc. | -68.16 Million USD | -304.58% |
| Clene Inc. | 3.34 Million USD | 8357.305% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1991.408% |
| BeyondSpring Inc. | -13.75 Million USD | -1905.045% |
| Synlogic, Inc. | -6.68 Million USD | -4025.565% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 24420.459% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3161.904% |
| Peak Bio, Inc. | 10.34 Million USD | 2767.213% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -234.62% |
| Krystal Biotech, Inc. | -350.23 Million USD | 21.254% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 322.191% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -63.196% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -8635.553% |
| MannKind Corporation | 143.89 Million USD | 291.658% |
| Ikena Oncology, Inc. | -109.15 Million USD | -152.66% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3542.768% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -733.215% |
| Gossamer Bio, Inc. | 180.35 Million USD | 252.917% |
| CohBar, Inc. | -5.93 Million USD | -4550.253% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -827.101% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6140.166% |
| Legend Biotech Corporation | -949.39 Million USD | 70.951% |
| Mural Oncology plc | -255.84 Million USD | -7.798% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 956.104% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -5754.701% |
| Disc Medicine, Inc. | -358.28 Million USD | 23.023% |
| Champions Oncology, Inc. | 4.81 Million USD | 5831.38% |
| REGENXBIO Inc. | 54.76 Million USD | 603.568% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -102461.108% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -82.616% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2960.295% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -241.824% |
| Vaxart, Inc. | -8.24 Million USD | -3246.608% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -449.61% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -116.878% |
| Cellectis S.A. | -43.85 Million USD | -528.877% |
| Longeveron Inc. | -2.9 Million USD | -9383.975% |
| Repare Therapeutics Inc. | -107.85 Million USD | -155.701% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 128.48% |
| Inozyme Pharma, Inc. | 12 Million USD | 2397.517% |
| Revolution Medicines, Inc. | -608.2 Million USD | 54.654% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -22322.276% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -4.027% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -83.774% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1662.6% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -37169.459% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.116% |
| Denali Therapeutics Inc. | -74.86 Million USD | -268.388% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2199.874% |
| Veru Inc. | 4.77 Million USD | 5869.786% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2352.374% |
| Cingulate Inc. | 3.08 Million USD | 9046.557% |
| Passage Bio, Inc. | 4.58 Million USD | 6115.136% |
| Context Therapeutics Inc. | -14.44 Million USD | -1808.632% |
| Exicure, Inc. | 5.84 Million USD | 4815.233% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -19.715% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -596.978% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1857.657% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -368.87% |
| Nuvalent, Inc. | -335.38 Million USD | 17.768% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 16001.948% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -270.283% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3002.295% |
| OmniAb, Inc. | 9.2 Million USD | 3096.784% |
| Anew Medical, Inc. | 1.43 Million USD | 19353.106% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1783.544% |
| Lipocine Inc. | -4.75 Million USD | -5700.582% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -151.114% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1910.741% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -444.413% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1207.962% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4003.467% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -318.968% |
| Ocugen, Inc. | -32.52 Million USD | -748.049% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -222.283% |
| Q32 Bio Inc. | -37.94 Million USD | -626.768% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -43816.242% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1938.539% |
| Equillium, Inc. | -22.39 Million USD | -1131.663% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -978.669% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -745.3% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -111145.387% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 305.752% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 8723.952% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 84070.637% |
| Dominari Holdings Inc. | 195 Thousand USD | 141532.821% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5136.353% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2992.901% |
| Bio-Techne Corporation | 267.74 Million USD | 203.005% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1601.487% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -133.538% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3182.09% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2080.017% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -12.514% |
| Nkarta, Inc. | 57.29 Million USD | 581.324% |
| BioCardia, Inc. | 212 Thousand USD | 130191.509% |
| Iterum Therapeutics plc | 13.43 Million USD | 2152.344% |